Allogeneic umbilical cord-derived mesenchymal stem cells for treating critical-sized bone defects: a translational study.

Ismail Hadisoebroto DilogoDina RahmatikaJeanne Adiwinata PawitanIsabella Kurnia LiemTri KurniawatiTera KispaFajar Mujadid

Published in: European journal of orthopaedic surgery & traumatology : orthopedie traumatologie (2020)

Umbilical cord mesenchymal stem cells are a potential new treatment for CSBDs. Additional studies with larger samples and control groups are required to further investigate the safety and efficacy of umbilical cord-derived mesenchymal stem cells for treating CSBDs.

Keyphrases

umbilical cord
mesenchymal stem cells
bone marrow
stem cell transplantation
cell therapy
bone mineral density
stem cells
risk assessment
low dose
combination therapy
case control
hematopoietic stem cell
body composition
climate change
bone regeneration